SpornM.B., NewtonD.L.Chemoprevention of cancer with retinoids. Fed Proc1979; 38: 2528–34.
2.
WattenbergL.W.Chemoprevention of cancer. Cancer Res1985; 45: 1–8.
3.
WillettW.C., MacMahonB.Diet and cancer – an overview (second of two parts). N Engl J Med1984; 310: 697–703.
4.
MettlinC., GrahamS., PrioreR., MarshallJ., SwansonM.Diet and cancer of the esophagus. Nutr Cancer1981; 2: 143–7.
5.
van MunsterI.P., NagengastF.M.The influence of dietary fibre on bile acid metabolism. Eur J Cancer Prev1991; 1(Suppl 2): 35–44.
6.
ThunM.J., HenleyS.J., PatronoC.Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst2002; 94: 252–66.
7.
SteinbachG., LynchP.M., PhillipsR.K.. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med2000; 342: 1946–52.
8.
PhillipsR.K., WallaceM.H., LynchP.M.. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut2002; 50: 857–60.
9.
LipkinM.Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res1988; 48: 235–45.
10.
BiascoG., ZannoniU., PaganelliG.M.. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev1997; 6: 469–71.
11.
HoltP.R., ArberN., HalmosB.. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev2002; 11: 113–9.
12.
RozenP., FiremanZ., FineN., WaxY., RonE.Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. Gut1989; 30: 650–5.
13.
BenitoE., ObradorA., StiggelboutA.. A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors. Int J Cancer1990; 45: 69–76.
14.
FreudenheimJ.L., GrahamS., MarshallJ.R., HaugheyB.P., CholewinskiS., WilkinsonG.Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol1991; 20: 368–74.
15.
WeijenbergM.P., BrinkM., LuchtenborgM.. Dietary factors, genetic susceptibility and somatic mutations in colorectal cancer: a prospective study. IARC Sci Publ2002; 156: 503–4.
16.
YunisJ.J., SorengA.L.Constitutive fragile sites and cancer. Science1984; 226: 1199–204.
17.
AlpersD.H.Adsorption of water-soluble vitamins, folate, minerals and vitamin D. In: SleisengerM.H., FortranJ.S., eds. Gastrointestinal Disease.Philadelphia: WB Saunders Co., 1983.
18.
MaJ., StampferM.J., GiovannucciE.. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res1997; 57: 1098–102.
19.
UlrichC.M., KampmanE., BiglerJ.. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?Cancer Epidemiol Biomarkers Prev1999; 8: 659–68.
20.
LevineA.J., SiegmundK.D., ErvinC.M.. The methylenetetrahydrofolate reductase 677C–>T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev2000; 9: 657–63.
21.
SlatteryM.L., PotterJ.D., SamowitzW., SchafferD., LeppertM.Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev1999; 8: 513–8.